Since IGFBP5 is a physiological regulator of epithelial cell survival in the mammary gland [23], it was proposed that a deregulation of IGFBP5 expression induced by variants located upstream of DIRC3 [24] could lead to the development of a breast tumour. Here, IGFBP5 is linked to breast neoplasm.